2006 - Complexity of patients with multiple chronic diseases

Chronic diseases represent a huge proportion of human illness. They include cardiovascular disease, cancer, chronic respiratory diseases and diabetes.

The main objectives of this Research Seminar are to discuss the:

burden of complex chronic co-morbidities and
relationship between markers of organ and systemic inflammation

The main educational aims are to:

define the most important and frequent co-morbidities in elderly patients, particularly those with COPD
provide updated information on the most common chronic disease, ie coronary and/or peripheral arterial diseases, systemic arterial hypertension, osteoporosis, metabolic syndrome, chronic heart failure, chronic obstructive pulmonary disease
emphasise the limitations of single disease-oriented clinical practice guidelines, and the need for a more comprehensive "internistic" approach to patients with multiple chronic co-morbidities
su

2006 - Complexity of patients with multiple chronic diseases

2023 - In Vitro Diagnostic (IVD) tests to combat antimicrobial resistance in community-acquired low-respiratory tract infections (CA-LRTI)

2024 - Sleep apnea and its consequences: from animal models to precision medicine

2019 - New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Overview of smoking-related disease

D. Mannino (Lexington, Ky, United States of America)

Replay

Slides

Accompanying documents

Osteoporosis and inflammation

N. Hamdy (Leiden, Netherlands)

Replay

Slides

Accompanying documents

Mechanisms of exacerbation of respiratory symptoms in patients with COPD

A. Anzueto (San Antonio, United States of America)

Replay

Slides

Accompanying documents

Development of new treatments for complex chronic comorbidities

P. J. Barnes (London, United Kingdom)

Replay

Slides

Accompanying documents

Role of anti-inflammatory treatments in complex chronic comorbidities

C. Page (London, United Kingdom)

Replay

Slides

Treatment strategies for patients with complex chronic comorbidities

J. Drazen (Boston, Ma, United States of America)

Replay

Slides

Accompanying documents

Mechanisms of exacerbation of respiratory symptoms in patients with metabolic syndrome

B. Muller (Basel, Switzerland)

Replay

Slides

Accompanying documents

Chronic inflammatory gastrointestinal diseases

F. Pallone (Rome, Italy)

Accompanying documents

Hypertension and inflammation

E. Schiffrin (Montreal, Canada)

Replay

Slides

Accompanying documents

The role of inflammation in COPD

R. Djukanovic (Southampton, United Kingdom)

Replay

Slides

Accompanying documents

Systemic effects of smoking

W. MacNee (Edinburgh, United Kingdom)

Replay

Slides

Accompanying documents

The role of inflammation in cachexia

P. Wagner (La Jolla, Ca, United States of America)

Replay

Slides

Accompanying documents

The role of inflammation in chronic heart failure

P. Poole-Wilson (London, United Kingdom)

Replay

Slides

Accompanying documents

The role of inflammation in myocardial infarction

F. Crea (Roma, Italy)

Replay

Slides

Accompanying documents

The role of inflammation in diabetes and obesity

M. Porta (Torino, Italy)

Replay

Slides

Accompanying documents

Sleep disorders in COPD and complex chronic comorbidities

W. McNicholas (Dublin, Ireland)

Replay

Slides

Accompanying documents

COPD and cancer

S. Spiro (London, United Kingdom)

Replay

Slides

Accompanying documents

COPD and CHF

F. Rutten (Utrecht, Netherlands)

Replay

Slides

Accompanying documents

COPD coronary/peripheral vascular disease

G. Mancini (Vancouver, British Columbia, Canada)

Replay

Slides

Accompanying documents

Mechanisms of exacerbation of respiratory symptoms in patients with CHF

P. M. A. Calverley (Liverpool, United Kingdom)

Replay

Slides

Accompanying documents

2006 - Complexity of patients with multiple chronic diseases

2006 - Complexity of patients with multiple chronic diseases

#{title}